Evidence map›Paper›PMID 35739438›Full record

Trial reportJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2022

Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trial.

Jason G Andrade, Laurent Macle, Matthew T Bennett, Nathaniel M Hawkins, Vidal Essebag, Jean Champagne, Jean-Francois Roux, Bhavanesh Makanjee, Anthony Tang, Allan Skanes and 11 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03199703 (Randomized Trial of Conventional Versus Radiofrequency Needle Transseptal Puncture for Cryoballoon Ablation), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03199703 nacompletednot on this map

Randomized Trial of Conventional Versus Radiofrequency Needle Transseptal Puncture for Cryoballoon Ablation

TypeinterventionalSponsorJason AndradeRan2017 to 2020Enrolled135ConditionsAtrial FibrillationArmsBaylis transseptal system group, Standard conventional transseptal group
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Angioplasty Guidewire-Assisted vs. Conventional Transseptal Puncture for Left Atrial Appendage Occlusion: a multicentre randomized controlled trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Trial
  2. Review
  3. Review
  4. Transseptal Device Comparison for Improved Puncture and Streamlined Mitral Edge-To-Edge Repair.Journal of the Society for Cardiovascular Angiography & Interventions · 2026
    Article
  5. Evolution of Radiofrequency Transseptal Puncture Devices.Medical devices (Auckland, N.Z.) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  12. Review
  13. Transcatheter Electrosurgery: A Narrative Review.Circulation. Cardiovascular interventions · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 16 institutions in 1 country.

Jason G AndradeUniversity of British Columbia, Vancouver, Canada. Jason.andrade@vch.ca.ORCID http://orcid.org/0000-0002-8493-5123
Laurent MacleMontreal Heart Institute, Université de Montréal, Montreal, Canada.
Matthew T BennettUniversity of British Columbia, Vancouver, Canada.
Nathaniel M HawkinsUniversity of British Columbia, Vancouver, Canada.
Vidal EssebagMcGill University Health Centre, Montreal, Canada.
Jean ChampagneUniversité Laval, Quebec, Canada.
Jean-Francois RouxUniversité de Sherbrooke, Sherbrooke, Canada.
Bhavanesh MakanjeeRouge Valley Centenary Hospital, Ajax, Canada.
Anthony TangUniversity of Western Ontario, London, Canada.
Allan SkanesUniversity of Western Ontario, London, Canada.
Yaariv KhaykinSouthlake Regional Health Center, Newmarket, Canada.
Carlos MorilloLibin Cardiovascular Institute, University of Calgary, Calgary, Canada.
Umjeet JollySt. Mary's Hospital, Kitchener, Canada.
Evan LockwoodRoyal Alexandra Hospital, Edmonton, Canada.
Guy AmitMcMaster University, Hamilton, Canada.
Paul AngaranSt. Michael's Hospital, University of Toronto, Toronto, Canada.
John SappDalhousie University, Halifax, Canada.
Stephan WardellUniversity of Saskatchewan, Saskatoon, Canada.
George A WellsUniversity of Ottawa Heart Institute, Ottawa, Canada.
Atul VermaMcGill University Health Centre, Montreal, Canada.
Marc W DeyellUniversity of British Columbia, Vancouver, Canada.
University of British Columbia · CAMcGill University Health Centre · CAWestern University · CADalhousie University · CAMcMaster University · CAMontreal Heart Institute · CARoyal Alexandra Hospital · CASouthlake Regional Health Center · CASt Mary's Hospital Centre · CASt. Michael's Hospital · CAUniversité de Sherbrooke · CAUniversité Laval · CAUniversity of Calgary · CAUniversity of Ottawa · CAUniversity of Saskatchewan · CAVancouver Coastal Health · CA

Funding

CANet SRG-15-P15-001EPA EP-C-15-001
6 · The paper itself

Abstract

backgroundTransseptal puncture to achieve left atrial access is necessary for many cardiac procedures, including atrial fibrillation ablation. More recently, there has been an increasing need for left atrial access using large caliber sheaths, which increases risk of perforation associated with the initial advancement into the left atrium. We compared the effectiveness of a radiofrequency needle-based transseptal system versus conventional needle for transseptal access.

methodsThis prospective controlled trial randomized 161 patients with symptomatic paroxysmal atrial fibrillation undergoing cryoballoon pulmonary vein isolation to transseptal access with a commercially available transseptal system (radiofrequency needle plus stiff pigtail wire; RF + Pigtail group) versus conventional transseptal access (standard group). The primary outcome was time required for left atrial access. Secondary outcomes included failure of the assigned transseptal system, radiation exposure, and complications.

resultsThe median transseptal puncture time was significantly shorter using the radiofrequency needle plus stiff pigtail wire transseptal system compared with conventional transseptal (840 ± 323 vs. 956 ± 407 s, P = 0.0489). Compared to conventional transseptal puncture, fewer transseptal attempts were required (1.0 ± 0.5 RF applications vs. 1.3 ± 0.8 mechanical punctures, P = 0.0123) and the fluoroscopy time was significantly shorter (72.0 [IQR 48.0, 129.0] vs. 93.0 [IQR 60.0, 171.0] s, P = 0.0490) with the radiofrequency needle plus stiff pigtail wire transseptal system. Failure to achieve transseptal LA access with the assigned system was rarely observed (1.3% vs. 5.7%, P = 0.2192). There were no procedural complications observed with either system.

conclusionsThe use of a radiofrequency needle plus stiff pigtail wire resulted in shorter time to left atrial access and reduced fluoroscopy time compared to left atrial access using conventional transseptal equipment.

trial registrationClinicalTrials.gov identifier NCT03199703.

Indexed as

Atrial FibrillationCatheter AblationHumansProspective StudiesPuncturesTreatment OutcomeCatheter ablationRadiofrequencyTransseptal puncture

Identifiers

PMID35739438
PMCPMC9640463
OpenAlexW4283383852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.